Home / Resource Library / TP53 and CD19 Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell LymphomaTP53 and CD19 Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma ASH 2021